Thank you for sharing!

Your article was successfully shared with the contacts you provided.
Merck to Pay $270M for Rights to Insomnia Treatment Drug Merck & Co. of Whitehouse Station announced last Tuesday it would pay $270 million to H. Lundbeck A/S of Denmark, a pharmaceutical company, for the U.S. rights to its gaboxadol insomnia treatment. Hoffmann-La Roche to Sell Drug Rights to Connetics Connetics Corp. of Palo Alto, Calif., a dermatology drug maker, agreed last Monday to pay $123 million for the U.S. rights to Soriatane, a psoriasis treatment, from Hoffmann-La Roche Inc. of Nutley, the U.S. prescription drug unit of the Roche Group of Switzerland. Wyeth Sells SPL for $81M Pharmaceutical maker Wyeth, of Madison, announced last Wednesday the $81 million sale of Scientific Protein Laboratories, a maker of pharmaceutical ingredients in Waunakee, Wis., to Arsenal Capital Partners L.P. of New York City, a private equity firm. Creative Beauty Supply to Merge With Global Digital Solutions Inc. Creative Beauty Supply Inc. of Totowa, a cosmetics and beauty supply distributor, agreed on Feb. 4 to merge with Global Digital Solutions Inc. of West Palm Beach, Fla., a communications company, in a $12 million reverse stock swap. The combined company will be called GDSI. Compiled by Amy E. Rice from Thomson Financial/Securities Data and other sources

This content has been archived. It is available exclusively through our partner LexisNexis®.

To view this content, please continue to Lexis Advance®.

Not a Lexis Advance® Subscriber? Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via Lexis Advance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at [email protected]


ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.